Article
Discussion: Managing Risk When Using Idelalisib.
Clinical advances in hematology & oncology
(2016)
Disciplines
- Pharmacology and
- Business
Publication Date
January 1, 2016
Citation Information
Steven E. Coutre, Jan A. Burger and John M. Pagel. "Discussion: Managing Risk When Using Idelalisib." Clinical advances in hematology & oncology Vol. 14 Iss. 5 (2016) p. 13 - 14 Available at: http://works.bepress.com/john-pagel/45/